Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Kidney Disease: early-phase trial registry
11 of 24 indexed Kidney Disease trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #686 of 28,707 conditions by registered trial count.
24 US clinical trials · 11 currently recruiting · #686 of 28,707 conditions by registered trial count
Kidney Disease: 24 US clinical trials tracked, 11 recruiting.
Kidney Disease is the subject of 24 registered US clinical trials on ClinicalTrials.gov, 11 of them currently open to new participants. 3 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), running 2 of these trials.
Enrollment posture brief
Registry condition kidney-disease
OPEN 11 | RECR 46% | LATE 3 | EARLY 6 | RANK #686 | SPON 2
Volume-matched condition peers
Nearest open-share peer: Glaucoma Open-Angle (46% recruiting · 24 trials)
Kidney Disease lists 11 open slots (46% of 24 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Kidney Disease on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Kidney Disease is recruiting above its size-band peers.
11 of 24 indexed trials (45.8%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
Sponsorship of Kidney Disease trials is spread across many organizations.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) accounts for 2 of 24 trials (8.3%). 22 distinct sponsors appear on at least one study for this condition label.
-
Typical Kidney Disease enrolment sits around 120 participants.
Median target enrolment is 120 among the 24 trials that report a genuine target (sentinel values excluded). 11 of those (45.8%) plan for fewer than 100 participants.
-
Kidney Disease splits between interventional and observational designs.
15 interventional and 9 observational studies make up this index (62.5% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
24 total, page 1 of 1
Rutgers University Study of the Genetics of Kidney Disease
Rutgers, The State University of New Jersey
NCT07217535
Immune System Related Kidney Disease
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00001979
A Multicenter, Prospective Blood Collection Study in a Kidney Transplant Population
Devyser
NCT07006831
A Study of Mezagitamab in Adults With Primary IgA Nephropathy Kidney Condition
Takeda
NCT06963827
Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment
Aventyn
NCT07403669
Randomized Trial of SGLT2i in Heart Transplant Recipients
VA Office of Research and Development
NCT06625073
Sensor-based Congestion ALert for Events in Peritoneal Dialysis (SCALE-PD)
Bodyport
NCT07059962
Outcomes of Physiologic Insulin Resensitization (PIR) in Patients With Chronic Kidney Disease and Type 2 Diabetes Mellitus
Well Cell Global
NCT07187479
Nicotinamide Riboside Supplementation for Treating Arterial Stiffness and Elevated Systolic Blood Pressure in Patients With Moderate to Severe CKD
University of Colorado, Denver
NCT04040959
Inspire HER: Inspiring the Heart and Emotions for Radical Health
University of Alabama at Birmingham
NCT06966258
A Study of Eloralintide (LY3841136) in Participants With Renal Impairment and in Participants With Normal Renal Function
Eli Lilly and Company
NCT07426380
Pediatric Acute Kidney Injury (AKI) Retrospective, Real-Time and Repository Research
Vanderbilt University Medical Center
NCT02660931
ISCHEMIA-Chronic Kidney Disease Trial
NYU Langone Health
NCT01985360
The Drug Induced Renal Injury Consortium
Ravindra Mehta
NCT02159209
Evaluation of New Test Method to Measure Kidney Function
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
NCT00026715
Prevention of Secondary Hyperparathyroidism With Vitamin D in Stage II/III Chronic Kidney Disease
Atlanta VA Medical Center
NCT00781417
A Prospective Study of Microalbuminuria in Untreated Boys With Alport Syndrome
University of Minnesota
NCT00622544
Fibroblast Growth Factor-23 (FGF23) Reduction in Predialysis Chronic Kidney Disease (CKD)
Myles Wolf
NCT00843349
DBS for Home Monitoring in Children With Kidney Transplantation
Oregon Health and Science University
NCT01931397
Study to Evaluate TRV120027 on Renal Pharmacodynamics in Patients With Heart Failure and Renal Dysfunction
Trevena
NCT01444872
Trial of Oral Glutamine on Mitochondrial Function in CKD
University of Washington
NCT02838979
Safety and Efficacy Study for AKB-6548 in Participants With Chronic Kidney Disease and Anemia
Akebia Therapeutics
NCT01235936
Combination Immunosuppressive Therapy to Prevent Kidney Transplant Rejection in Adults
University of Wisconsin, Madison
NCT00078559
Role of Nox2 in CNI-induced Renal Fibrosis
University of Wisconsin, Madison
NCT01674465
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 3 |
| Phase 2 | 3 |
| Phase 3 | 1 |
| Phase 4 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Kidney Disease records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Kidney Disease trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Kidney Disease page
24 registered trials, 11 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 11 Kidney Disease trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) sponsors the most Kidney Disease trials on record, review their full trial history before evaluating a specific study. See National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)'s trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Kidney Disease condition card totals 24 registered trials; most-linked intervention Placebo; top US site state Georgia. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.